Research Paper Volume 16, Issue 10 pp 8944—8964

SLAMF8 can predict prognosis of pan-cancer and the immunotherapy response effectivity of gastric cancer

class="figure-viewer-img"

Figure 1. SLAMF8 expression in pan-cancer. (A) Expression levels of SLAMF8 in a database contain 31 normal tissues, obtained from the GTEx. (B) Expression levels of SLAMF8 in a dataset containing 21 tissues in tumor cell lines, collected from the CCLE. (C) Expression levels of SLAMF8 in tumor and paired adjacent noncancerous tissues containing 20 tissues from TCGA, *P < 0.05, **P < 0.01, and ***P < 0.001. (D) SLAMF8 expression difference in 27 tumors integrating data of normal tissues in GTEx database and data of TCGA tumor tissues, *P < 0.05, **P < 0.01, and ***P < 0.001.